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Background: Availability of a patient data management system (PDMS) has created the opportunity to develop
trigger-based electronic surveillance systems (ESSs). The aim was to evaluate a semi-automated trigger-based ESS
for the detection of ventilator-associated pneumonia (VAP) and central line-associated blood stream infections
(CLABSIs) in the intensive care.
Methods: Prospective comparison of surveillance was based on a semi-automated ESS with and without trigger.
Components of the VAP/CLABSI definition served as triggers. These included the use of VAP/CLABSI-related antibiotics,
the presence of mechanical ventilation or an intravenous central line, and the presence of specific clinical symptoms.
Triggers were automatically fired by the PDMS. Chest X-rays and microbiology culture results were checked only
on patient days with a positive trigger signal from the ESS. In traditional screening, no triggers were used; therefore,
chest X-rays and culture results had to be screened for all patient days of all included patients. Patients with pneumonia
at admission were excluded.
Results: A total of 553 patients were screened for VAP and CLABSI. The incidence of VAP was 3.3/1,000 ventilation days
(13 VAP/3,927 mechanical ventilation days), and the incidence of CLABSI was 1.7/1,000 central line days (24 CLABSI/13.887
central line days). For VAP, the trigger-based screening had a sensitivity of 92.3%, a specificity of 100%, and a negative
predictive value of 99.8% compared to traditional screening of all patients. For CLABSI, sensitivity was 91.3%, specificity
100%, and negative predictive value 99.6%.
Conclusions: Pre-selection of patients to be checked for signs and symptoms of VAP and CLABSI by a
computer-generated automated trigger system was time saving but slightly less accurate than conventional
surveillance. However, this after-the-fact surveillance was mainly designed as a quality indicator over time rather than
for precise determination of infection rates. Therefore, surveillance of VAP and CLABSI with a trigger-based ESS is
feasible and effective.
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Manual surveillance of hospital-acquired infections (HAIs)
by infection prevention practitioners (IPPs) is very labor
intensive and vulnerable to misclassification. According to
Stone et al. [1], IPPs spend on average 45% of their work-
ing time on surveillance and analysis. Together with the
trend towards mandatory and public reporting of HAI
rates [2], this underscores the need for more effective sur-
veillance efforts. Surveillance also secures a follow-up on
the outcome of interventions directed at HAIs [3].
Over the last years, electronic surveillance systems
(ESSs) for infection control programs have evolved rapidly
and have led to a reduction of workload and thereby costs
[1,4] to improve efficiency, objectivity, and reproducibility
of surveillance [5-7]. ESSs make surveillance more con-
sistent and comparable [8]. This ongoing development of
ESSs also benefits from developments of decision support
capabilities [7,9], classification algorithms [3,10], and re-
gression models [11].
The objective of this study was to evaluate an ESS for
HAI surveillance with decision support capabilities in
the intensive care unit (ICU), a so-called trigger-based
ESS. We compared this screening method with our
existing traditional daily screening of all admission days
for signs and symptoms of HAI.
Since central line-associated bloodstream infection
(CLABSI) and ventilator-associated pneumonia (VAP)
are the most predominant HAI in an ICU setting [12],
we chose these as outcome parameters. Also, VAP and
CLABSI are notoriously difficult to diagnose which
makes a consistent computer-based system potentially
appealing [12,13].Methods
Setting
This study was conducted in the ICU department of VU
University Medical Centre, Amsterdam. The ICU is a
mixed ICU with 24 beds. In nearly all hospitals in the
Netherlands, selective decontamination of the digestive
tract (SDD) is used as standard prophylaxis for VAP in
patients admitted for >48 h.
In our hospital, SDD consists of cefotaxime iv during
the first 3 days of stay in the ICU and enteral administra-
tion of 64 mg tobramycin, 100 mg colistin, and 500 mg
amphotericin B four times daily. A paste containing tobra-
mycin 2%, amphotericin B 2%, and colistin 2% is applied
to the buccal mucosa four times daily.Ethical approval
Surveillance of nosocomial infections is part of the regu-
lar quality control program of the hospital, performed in
compliance with the Helsinki Declaration and as such
waved by the institutional review board.Data collection
Patient data are stored in a hospital management data-
base (HMDB) system, a clinical data warehouse. Patient
data include age, sex, date of admission and discharge,
radiology reports, blood parameters, and microbiological
results. In addition, the ICU has a dedicated patient data
management system (PDMS; MetaVision®, iMDsoft, Tel
Aviv, Israel). The PDMS contains all relevant informa-
tion related to the ICU and integrates automatically rele-
vant patient-related data derived from the HMDB. Since
2005, the PDMS and HMDB are used for VAP surveil-
lance in the ICU. Data collection in the PDMS is mostly
automated (e.g., blood pressure, ventilation data) by a
direct link to the equipment. Orders and specifications
as given by doctors and nurses (e.g., orders for antibi-
otics, description of sputum appearance) are entered
into the PDMS manually. Data collection in the PDMS
is according to ICU quality protocols and standards.
The information technology expert on our ICU has de-
veloped a program (VB.net), which runs weekly. VB.net
retrieves the daily surveillance-relevant data from the
PDMS and transforms them into scores. Then, the algo-
rithm determines if there is a VAP/CLABSI trigger per
day, and finally, the data are added to the Access database.
Surveillance methods
From October 2009 till October 2010, surveillance of
VAP and CLABSI was conducted both with trigger activa-
tion (trigger-based ESS) and without trigger activation
(gold standard). An infection prevention research coordin-
ator performed the surveillance, and the presence of VAP
or CLABSI was assessed in cooperation with an experi-
enced intensive care physician. In the trigger-based ESS,
patients with a possible VAP or CLABSI were pre-selected
by a trigger signal (automated part), which showed up
when all criteria of the automated part were fulfilled
(based on factors a to d, see Figure 1). These automated
factors were clearly defined in the PDMS and needed no
manual interpretation. The algorithm determined daily
whether to fire a trigger for VAP or CLABSI. Data that
had activated the trigger were retrieved automatically into
the Access database. The remaining criteria (factors e and
f, see Figure 1) to be met to confirm the presence of VAP
or CLABSI were then checked manually, only for the pa-
tients with an active trigger. For traditional screening
without trigger, factors e and f were checked manually for
all patients under surveillance every day. Data on factors e
and f were entered in the Access database by the research
coordinator. The manual screening for criteria e and f was
performed approximately 2 weeks after discharge of the
patient, when results of microbiological cultures were
known and radiology reports were accessible. The active
part of the surveillance (checking of microbiological re-
sults and/or X-rays results) required approximately 1 min
trigger active and and and
trigger not active and and and
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Figure 1 Illustration of how automated and active parts trigger surveillance. Legend: a-d, factors relevant for trigger activation; e,f, factors
of the active part of the surveillance.
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screening, we totaled all patient days to calculate the
workload. In the trigger-based ESS, only triggered patient
days were taken into account. All patient days where the
trigger did not fire represent saved time.
Definitions of VAP/CLABSI
CDC definitions [14] of VAP and CLABSI were slightly
amended to allow automatic assessment (see Figures 2
and 3). Only the first episode of CLABSI or VAP per ad-
mission was included, as it is difficult to distinguish the
beginning and end of a separate episode.
For VAP, the trigger was activated when the patient
had mechanical ventilation and was given specific antibiotics
for VAP treatment (ceftriaxone, levofloxacin, ciprofloxa-
cin, sulfamethoxazole and trimethoprim (cotrimoxazole),
ceftazidime, tobramycin, gentamicin, imipenem, flucona-
zole, and voriconazole), in combination with one of the
following clinical symptoms: temperature above 38°C,
white blood cell count <4,000 or >12,000/mm3, and pres-
ence of purulent sputum. For every occurring sputum,
nurses fill in the PDMS with descriptions such as option-
ally purulent, white, or yellow sputum. The CDC sign








Figure 2 Diagnostic algorithm to identify cases of VAP.included the presence of lung infiltrates/consolidations in
radiology reports on at least two consecutive days. Rapidly
disappearing (<1 day) densities on the chest X-ray were
considered not to be related to VAP but to (hydrostatic)
transient edema. These X-ray findings were verified by the
radiologist. The definitive diagnosis was confirmed in co-
operation with the experienced intensive care physician.
When the diagnosis of VAP was not conclusive, the results
of sputum/BAL cultures and respiratory deterioration were
taken into account.
To indicate suspected CLABSI, the trigger was activated
when one of the following central lines was present -
arterial, dialysis, single lumen, double lumen, triple lumen,
and quadruple lumen - and when CLABSI-specific antibi-
otics were used (vancomycin, flucloxacillin, ceftriaxone,
ciprofloxacin, imipenem, fluconazole, and voriconazole),
in combination with one of the following clinical symp-
toms: temperature above 38°C and hypotension with a
systolic pressure <90 mmHg (see Figure 3). The CDC sign
‘presence of cold shivers’ for CLABSI was not used. The
active part included the evaluation of the culture results of
blood and central line samples. The microbiological culture
policy for CLABSI was as follows: in case of temperature
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Figure 3 Diagnostic algorithm to identify cases of CLABSI.
Table 1 Patient characteristics (n = 553)
Value
Age (year), mean, SD, range 62.5 ± 15.8 (16 to 96)
Gender (male), mean, range 343 (62%) (16 to 96)
APACHE II score, mean, SD, range 24.2 ± 7.9 (0 to 49), 46 missing
ICU length of stay (days), mean, SD, range 11.7 ± 11.6 (2 to 56)
ICU mortality, n (%) 127 (23%)
Pneumonia on admission, n (%) 131 (25%)
Mean (SD), or number (percentage), when appropriate.
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ous central line that was in place at that moment. If one
or more central lines were removed, the tip was sent for
culture. At least ten colonies of the pathogen had to be
found optionally in a catheter tip sample. At least one
catheter tip or blood sample had been taken from all pa-
tients with clinical symptoms for CLABSI. Catheter tip
colonization was diagnosed by a qualitative method: the
catheter tip was vigorously shaken in 1 ml sodium chlor-
ide, and 100 μl of this suspension was subcultured on agar
plates. Growth was reported as +, ++, or +++. Culture re-
sults were interpreted in the context of the clinical signs
and symptoms (contaminant vs pathogen) and the presence
of other foci of infection.
Patient selection
We included patients with a minimal length of ICU stay
(LOS) of 48 h and evaluated for a maximum of 8 weeks
of stay. Patients with pneumonia on admission were ex-
cluded. The presence of mechanical ventilation, the use of
specific antibiotics, and clinical criteria were retrieved
daily from the PDMS. Central line days and ventilation
days, respectively, were registered automatically until ICU
discharge or death; in case of CLABSI or VAP, they were
registered until the day of infection. Patients readmitted to
the ICU >24 h after discharge were considered new pa-
tients. Patients in whom life-prolonging treatment was
stopped were excluded from the analysis from that mo-
ment on, taking into account that no further diagnostics is
done nor specific antibiotic treatment is given anymore.
Missing values
Factors of the automated part of the surveillance were
mandatory: no missing data were allowed. In cases that
there was no information on the presence of pneumonia
on admission, this field was corrected during the active
phase of the surveillance (based on the patient's chart).
Sometimes, administrative data (in particular for history
of the patient) were missing. This, however, would not
affect the results [15].
Statistical analysis
Analysis was performed with SPSS® version 15 (SPSS
Inc., Chicago, IL, USA) and Microsoft Excel® (MicrosoftOffice 2010, Microsoft Corporation, Redmond, WA,
USA). The two screening methods were compared by
calculating the sensitivity, specificity, and positive and
negative predictive values.
Results
During the study period, 553 patients were included,
with a total of 6,793 patient days of stay (see Table 1).
Two patients were excluded from the study for further
analysis from the moment that life-prolonging treatment
was stopped, accounting for 28 patient days (0.4%). In
our setting, all patients identified with VAP or CLABSI
through the trigger screening were also identified through
traditional screening (positive predictive value: 100%);
all patients with no VAP or CLABSI in trigger screening
were also identified as such through traditional screening
(specificity: 100%), as a reference gold standard.
VAP
A total of 131 patients were diagnosed with pneumonia
on admission to the ICU and were excluded from the
VAP registration. Thirteen of the remaining 422 patients
(3.0%) acquired VAP during their stay. The patients had
a total length of stay of 6,793 days; on 359 (5.3%) of
these days, the ESS showed a VAP trigger. With 3,927
mechanical ventilation days, the incidence of VAP in
traditional screening was 3.3/1,000 ventilation days,
(95% confidence interval (CI): 1.5 to 5.1). By traditional
screening, VAP was diagnosed in 13 patients (see
Table 2). One of these patients was not identified by the
trigger system and hence was not diagnosed with VAP.
For this patient, the treatment was started 3 days after
the development of clinical symptoms and infiltrates on
Table 2 The performance of a trigger screening for detection of VAP and CLABSI
Group 2 (gold standard) Sensitivity, % (95% CI) Specificity, % (95% CI) PPV, % (95% CI) NPV, % (95% CI)
Group 1 (trigger-based) VAP No VAP Total VAP 12/13 409/409 12/12 409/410
VAP 12 0 12 92.3% 100.0% 100.0% 99.8%
No VAP 1 409 410 (63.90 to 98.72) (99.09 to 100.00) (73.35 to 100.00) (98.64 to 99.96)
Total VAP 13 409 422
CLABSI No CLABSI Total CLABSI 22/24 529/529 22/22 529/531
CLABSI 22 0 22 91.7% 100.0% 100.0% 99.6%
No CLABSI 2 529 531 (72.96 to 98.73) (99.30 to 100.00) (84.43 to 100.00) (98.64 to 99.94)
Total CLABSI 24 529 553
PPV, positive predictive value; NPV, negative predictive value.
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dence determined with the trigger system was 3.1/1,000
ventilation days, (95% CI: 1.3 to 4.8). The sensitivity of
the trigger screening was 92.3% (95% CI: 63.9% to 98.7%).
The trigger-based ESS correctly identified 409 out of the
410 patients who did not develop VAP. This finding re-
sults in a negative predictive value of 99.8% (95% CI:
98.6% to 100%) for the VAP trigger. All patients with VAP
in trigger screening were confirmed by traditional screen-
ing (100% positive predictive value), and all patients with-
out VAP with trigger screening had no VAP according to
traditional screening (100% specificity). In 359 of the
6,793 patient days (5.3%), the VAP trigger was activated.
CLABSI
Of the 553 inclusions, 24 patients (4.3%) acquired a
CLABSI during admission in the ICU during 13.887 cen-
tral line days. The incidence in traditional screening for
CLABSI was 1.7/1,000 central line days (95% CI: 1.0
to 2.4). Of the 6,793 patient days, 983 days were with an
active CLABSI trigger (14.5%). By traditional screening,
CLABSI was diagnosed in 24 patients. Two of them
were not identified by the trigger system. Their central
line had been removed, and they had not received anti-
biotic treatment.
The CLABSI incidence with the trigger system was
1.6/1,000 central line days, (95% CI: 0.9 to 2.2). The sen-
sitivity of the trigger screening was 91.3% (95% CI:
73.0% to 98.7%), as 22 out of 24 CLABSI were identified
through trigger screening (see Table 2). Five hundred
twenty-nine of the total 531 inclusions without CLABSI
were identified by the trigger system. This finding results
in a negative predictive value of 99.6% (95% CI: 98.6% to
99.9%) for the CLABSI trigger screening. All patients
with CLABSI in trigger screening were confirmed by
traditional screening (100% positive predictive value),
and all patients without CLABSI with trigger screening
had no CLABSI according to traditional screening (100%
specificity).
In 983 of the 6,793 patient days (14.5%), the CLABSI
trigger was activated. Together for VAP and CLABSI,trigger activation occurred in about 20% of the patient
days, both for VAP (5.3% active trigger) and CLABSI
(14.5% active trigger).
Total manual labor time for traditional screening
amounted to 226 days (time needed for checking of 6,793
patient days of stay in the ICU). This makes 4.4 h/week
for checking for both CLABSI and VAP. Trigger-based
screening reduced labor time to 22 h for 1,342 days, since
triggers were activated on 1,342 of the 6,793 patient days,
359 times for VAP and 983 times for CLABSI. For VAP,
labor time with trigger screening was reduced from 2.2 to
0.3 h/week, and for CLABSI, labor time with trigger
screening was reduced from 2.2 to 0.1 h/week. In sum-
mary, manual labor time for screening and determination
of infection was reduced by 90% from an original 4.4 h
per week to 26 min per week.
Discussion
In this study, we compared detection of VAP and CLABSI
on the ICU by two surveillance methods: one with a
trigger-based ESS and one without a trigger-based ESS
(gold standard). The trigger-based ESS showed high sensi-
tivity and negative predictive value when compared with
the system without trigger.
Compared to the gold standard, the trigger-based ESS
resulted in a workload reduction of 90%. This is a rough
estimation of saved time. The principle of a trigger-based
surveillance is not new: Klompas et al. developed in 2008
an algorithm for surveillance of VAP, where only patients
who met ventilator-change criteria were examined further
to see whether they fulfilled the remaining criteria for
VAP [8]. In 2011, Klompas used ventilator-associated
complications (VACs) as a faster and more objective
predictor of outcomes versus VAP [13]. Woeltje et al.
developed an automated CLABSI surveillance based on
laboratory data where combinations of dichotomous
prediction rules were applied to electronic data [10]. Be-
cause not all types of CLABSI require positive microbiol-
ogy results to meet case definitions, basing the initial case
finding on microbiology results only will lead to lower
sensitivity of detection. This is also dependent on the
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we developed for CLABSI surveillance, microbiology re-
sults were not used as components of the trigger system
but were used in the active part of the surveillance. This
was done to interpret the microbiological results in the
context of the diagnoses of CLABSI. A trigger system will
not be suitable for every type of infection or every depart-
ment in a hospital. The higher the incidence of an out-
come parameter, the more frequently the trigger will be
activated. Hence, an automated trigger surveillance system
is most time effective in case of a low incidence of the out-
come parameter. In our ICU, the incidence of VAP is very
low, related to the use of SDD and strict adherence to
guidelines on oral hygiene and bronchial suction. In sev-
eral studies, SDD has shown to be very effective in redu-
cing the incidence of VAP [16]. This trigger-based ESS
is developed for the purpose of retrospective HAI sur-
veillance, not for real-time surveillance. The trigger pre-
selects potential cases of VAP and CLABSI based on a
simple algorithm of clinical treatment factors. VAP and
CLABSI definitions however are difficult to apply ob-
jectively [12]. To make surveillance more consistent and
reproducible, we used slightly modified VAP/CLABSI
criteria. This might have influenced the outcome: sur-
veillance HAI definitions are commonly less specific
than the clinical diagnosis [8,12].
One of the limitations of the trigger-activated ESS that
we propose is that the trigger activation depends on the
strict adherence of ICU physicians to the antibiotic pol-
icy that is agreed for treatment of VAP and CLABSI. A
second drawback is that infections that are not treated
with antibiotics will go undetected. This probably is not
really an issue for VAP but might lead to underestima-
tion of CLABSI, because a possible CLABSI might be
treated by simple central line removal without antibiotic
treatment. In our ICU, rigorous guidelines are used for
antibiotic treatment of VAP and CLABSI. Therefore, we
were able to base the algorithm that fires the trigger on
the start of antibiotic treatment. In addition, clinical pa-
rameters that are important in the diagnosis of VAP and
CLABSI are recorded routinely in the PDMS. This per-
mitted the inclusion of these parameters in the auto-
mated and hence objective part of the algorithm. The
manual part included the evaluation of radiographic
signs for VAP and the interpretation of blood culture re-
sults for CLABSI. This interpretation can be subjective,
and therefore, for all VAP and CLABSI, it was performed
by two persons and discussed until consensus was
reached. As our study is a surveillance after the fact, it
has no influence on an individual patients' treatment,
and therefore, the missing two cases of CLABSI would
not appear as a significant problem.
Another weakness of our surveillance is the short
study period and the low number of VAP and CLABSIcases, and the high sensitivity and negative predicted values
we measured might be due to this limitation [17].
Future steps will be to create a uniform comparable
surveillance system, taking into account that the trigger
will have to be adjusted for every hospital according to
the local antibiotic policy [11].
Further reduction of the manual part of the surveillance
system remains the next goal. Haas et al. [18] evaluated
the utility of natural language processing to search radio-
graphic reports for descriptions suggestive of pneumonia
in a neonatal intensive care unit. Another challenge is
real-time surveillance [4]. This is hampered by the lack of
real-time availability of complete microbiological culture
results and radiographic reports.
Van Mourik et al. [11] showed that models with mul-
tiple indicators or predictors of drain-related meningitis
simultaneously achieved near-perfect sensitivity. How-
ever, HAI definitions require a clinical judgement [12],
and automated data alone are not sufficient to confirm
their presence [19]. Mayer et al. [20] showed that agree-
ment in classifying CLABSI among multiple reviewers
conducting surveillance is poor. She emphasized that the
reliability of a non-fully automated surveillance to identify
hospital infections may be ideal for surveillance within a
hospital, but not for inter-hospital comparisons.
Conclusions
Pre-selection of patients to be checked for signs and
symptoms of VAP and CLABSI by a computer-generated
automated trigger system was time saving but slightly less
accurate than conventional surveillance. However, this
after-the-fact surveillance was mainly designed as a quality
indicator over time rather than for precise determination
of infection rates. Therefore, surveillance of VAP and
CLABSI with a trigger-based ESS is feasible and effective.
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